Rain Therapeutics Competitors and Similar CompaniesClear all
Rain Therapeutics's competitors and similar companies include Five Prime Therapeutics, ImmunoGen, Aeglea and Aptevo Therapeutics.
 Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. |  Five Prime Therapeutics Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. | |
Founding Date | Founding Date 2017 | Founding Date 2001 | Founding Date 1981 | Founding Date 2013 | Founding Date 2016 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Newark, US HQ | Locations South San Francisco, US HQ | Locations Waltham, US HQ | Locations Austin, US HQ | Locations Seattle, US HQ |
Employees | Employees 6343% increase | Employees 5141% decrease | Employees 277161% increase | Employees 65117% increase | Employees 1182% decrease |
Valuation ($) | Valuation ($) 44 m | Valuation ($) N/A | Valuation ($) 8.7 b | Valuation ($) 48.6 m | Valuation ($) 4.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $13.2m (FY, 2020) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($75.7m) (FY, 2022) | Net income ($84.3m) (FY, 2020) | Net income ($222.9m) (FY, 2022) | Net income ($155.2m) (FY, 2025) | Net income ($26m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 82.4m | Total funding raised $ 237.2m | Total funding raised $ 56m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Five Prime Therapeutics
HQ
South San Francisco, US
Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.
View companyImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View companyAeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyAptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View company